News, musings and commentary on pharmaceutical law issues, technology, and litigation.
No advice, though.
Lawyers for consumers and injured people.(No advice on this blog, though) TOLL FREE 855-525-3955
Tuesday, May 23, 2006
NYT Article on Vioxx and Why The Data Differs
It's worth signing up for the New York Times to read the recent weekend article regarding the data recently released. The article is titled, "Vioxx Data Suggest Risks Started Earlier."
I posted on that subject last week, which you can read here.